Litigation Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)

Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)

Docket		Date Filed	2020-08-21
Court	District Court, D. Delaware	Date Terminated	2023-02-24
Cause	35:271 Patent Infringement	Assigned To	Maryellen Noreika
Jury Demand	None	Referred To
Parties	DR. REDDYS LABORATORIES, LTD.
Patents	10,047,117; 10,052,337; 10,174,073; 7,138,390; 9,238,673
Attorneys	Lance A. Soderstrom
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2022-02-03	115	Joint Claim Construction Brief	“’673 Patent” refers to U.S. Patent No. 9,238,673.  “’117 Patent” refers to U.S. Patent No. 10,047,117…“’073 Patent” refers to U.S. Patent No. 10,174,073.  “’337 Patent” refers to U.S. Patent No. 10,052,337…“’349 Patent” refers to U.S. Patent No. 10,751,349.  “’549 Patent” refers to U.S. Patent No. 10,758,549…compositions—expire. Patents from three patent families are asserted in this case. The ’673 Patent Family, which…and ’073 Patents, and the ’337 Patent Family, which includes the ’337, ’349, and ’549 Patents. The ’673	External link to document
2022-02-28	137	Claim Construction Chart	regarding U.S. Patent No. 9,238,673 (“the ’673 Patent”), U.S. Patent No. 10,047,117 (“the ’117 Patent”), U.S.…U.S. Patent No. 10,174,073 (“the ’073 Patent”), U.S. Patent No. 10,052,337 (“the ’337 Patent”), U.S. Patent… ’349 Patent”), and U.S. Patent No. 10,758,549 (“the ’549 Patent”) (collectively, the “Patents-in-Suit…particles 1 U.S. Patent No. RE48,286 (“the RE286 Patent”) is also an asserted patent in this case. It … ’673 Patent (claims 1–23) ’073 Patent (claims	External link to document
2022-03-23	142	Order - -Memorandum and Order	terms of U.S. Patent Nos. 9,238,673 (“the ’673 Patent”), 10,047,117 (“the ’117 Patent”), 10,174,073 …of the ’673 Patent, the ’117 Patent, the ’337 Patent, the ’349 Patent, and the ’549 Patent are construed…10,174,073 (“the ’073 Patent”), 10,052,337 (“the ’337 Patent”), 10,751,349 (“the ’349 Patent”), and 10,758,549… matter” (’337 Patent, claims 1–8; ’349 Patent, claims 1, 19; ’549 Patent, …meaning (’337 patent, claim 11; ’349 patent, claim 4; ’549 patent, claims 12, 23	External link to document
2020-11-12	15	Complaint - Amended	expiration of U.S. Patent Nos. 9,238,673 (filed June 17, 2013) (“the ’673 patent”); 10,047,117 (filed Nov. …Notification of Certification for U.S. Patent Nos. 9,238,673; 10,047,117; 10,052,337; and 10,174,073 (NDA … ’073 patent”); 10,758,549 (filed Feb. 11, 2020) (“the ’549 patent”) (collectively the “patents-in-suit… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…20, 2015) (“the ’117 patent”); 10,052,337 (filed Apr. 26, 2016) (“the ’337 patent”); 10,174,073 (filed	External link to document
2020-11-12	16	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 9,238,673 B2; 10,047,117 B2; 10,052,… 21 August 2020 1:20-cv-01105 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-08-31	226	Exhibit Volume 1 - Part 1 (A1 and 1 through 40)	States Patent Nos. RE48,286 (“the RE286 patent”); 9,238,673 (“the ’673 patent”); 10,047,117 (“the ’…6700 RE286 Patent”);1 9,238,673 (filed June 17, 2013) (“the ’673 Patent”); 10,047,117 (filed Nov. 20…6736 15. U.S. Patent No. 10,047,117 (“the ’117 patent”), entitled “Preparations and Uses…’673 patent, ’117 patent, ’337 patent, RE286 patent, ’073 patent, ’549 patent, and ’349 patent to be… ’673 patent, ’117 patent, ’337 patent, RE286 patent, ’073 patent, ’549 patent, and ’349 patent. The	External link to document